Other substances

Ridogrel

A thrombolytic trifluoromethylbenzene.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Ridogrel on PubChem

 

Structure image - Ridogrel

C1=CC(=CC(=C1)C(F)(F)F)/C(=N\OCCCCC(=O)O)/C2=CN=CC=C2

Supporting references

Link Tested on Impact factor Notes Publication date
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 [version 1; peer review: 2 approved]
RdRpol Small molecule In silico 		in silico 2.64

Predicted to bind the active site of the SARS-CoV-2 RNA-dependent RNA polymerase.

 Sep/23/2020

AI-suggested references

Link Publication date
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
Apr/28/2021
Export (.csv)